John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP
  • Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease

    Circulation Date published:
  • ADVANCE-Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline

    Diabetic Medicine Date published:
  • Effects of Different Blood Pressure-Lowering Regimens on Major Cardiovascular Events in Individuals With and Without Diabetes Mellitus

    ARCHIVES OF INTERNAL MEDICINE Date published:
  • ADVANCE: action in diabetes and vascular disease

    Journal of Human Hypertension Date published:
  • Blood pressure in acute stroke: in search of evidence

    Journal of Hypertension Date published:
  • Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease

    Hypertension Date published:
  • Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA

    Date published:
  • Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons

    Date published:
  • Perindopril-Based Blood Pressure-Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack

    Stroke Date published:
  • The PROGRESS trial three years later: time for more action, less distraction

    BMJ Date published:
  • Effects of an Angiotensin-converting Enzyme Inhibitor-based Regimen on Pneumonia Risk

    American Journal of Respiratory and Critical Care Medicine Date published:
  • Effects of Perindopril-Based Blood Pressure Lowering and of Patient Characteristics on the Progression of Silent Brain Infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan

    Hypertension Research Date published:
  • Perindopril-based blood pressure lowering in individuals with cerebrovascular disease

    Journal of Hypertension Date published:
  • Effects of a Perindopril-Based Blood Pressure-Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History

    Stroke Date published:
  • Amino-terminal pro-brain-type natriuretic peptide and C-reactive protein predict development of heart failure in subjects with cerebrovascular disease

    Date published:
  • Effects of perindopril-based blood pressure lowering on the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial

    Date published: